Related Experiment Video
Updated: Jul 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary
Jacek Kowalczyk1, Radoslaw Lenarczyk, Oskar Kowalski
11st Department of Cardiology, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland. jacekmed@poczta.onet.pl
Insights
Chronic kidney disease (CKD) significantly worsens long-term survival in acute myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI). Contrast-induced nephropathy (CIN) further elevates mortality risk in these vulnerable patients.
Area of Science:
- Cardiology
- Nephrology
- Clinical Medicine
Background:
- Prognostic impact of renal dysfunction in acute myocardial infarction (AMI) patients post-percutaneous coronary intervention (PCI) remains unclear.
- Renal dysfunction is common in AMI patients, potentially affecting outcomes after PCI.
Purpose of the Study:
- To investigate the prognostic significance of chronic kidney disease (CKD) and its subtypes in AMI patients treated with PCI.
- To determine the impact of contrast-induced nephropathy (CIN) on long-term survival in AMI patients with CKD.
Main Methods:
- Retrospective analysis of 1,486 consecutive AMI patients treated with PCI.
- Patients categorized into CKD (eGFR <60 mL/min/1.73 m2) and normal renal function groups.
- CKD group further stratified into those with (CKD + CIN) and without (CKD-CIN) contrast-induced nephropathy.
Main Results:
- Higher remote mortality rates observed in the CKD group (34.6%) compared to controls (9.1%).
- CKD was an independent predictor of all-cause death (HR 1.77).
- CKD + CIN subgroup showed significantly higher mortality (47.0%) and was an independent risk factor (HR 2.16) compared to CKD-CIN (31.0%).
Conclusions:
- CKD negatively impacts long-term survival in AMI patients undergoing PCI.
- Contrast-induced nephropathy exacerbates mortality risk in CKD patients with AMI.
- Identifying and managing renal dysfunction, especially CIN, is crucial for improving outcomes in AMI patients.
Background:
The prognostic significance of different types of renal dysfunction in patients with acute myocardial infarction (AMI) treated with percutaneous coronary intervention (PCI) has not been well characterized.
Methods:
The single-center AMI registry encompassed 1,486 consecutive AMI patients treated with PCI, who were followed by mean 29.7 months. Subjects with an estimated glomerular filtration rate <60 mL/min per 1.73 m2 at baseline were selected (n = 283, 19.0%) and incorporated into the chronic kidney disease (CKD) group. The control group consisted of 1,203 subjects with normal renal function (81.0%). The CKD patients were divided into subgroups: with contrast-induced nephropathy - CKD + CIN (n = 68, 4.6%) and without - CKD-CIN (n = 215, 14.5%).
Results:
Remote mortality rate was significantly higher in CKD group (34.6%) and in particular subgroups: CKD + CIN (47.0%), CKD-CIN (31.0%) than in controls (9.1%, P < 0.001 for all study groups vs controls). Multivariate analysis identified CKD as an independent predictor of any-cause death in the whole population (hazard ratio [HR] 1.77, 95% confidence interval [CI] 1.60-1.94, P < 0.001). Similarly, CKD + CIN contrary to CKD-CIN had significant and independent influence on remote survival in study population (HR 2.16, 95% CI 1.95-2.37, P < 0.001).
Conclusions:
CKD and its types have significant, negative influence on long-term survival in AMI patients treated with PCI. It is especially strongly expressed in those CKD patients who develop contrast-induced nephropathy, which occurrence is an independent risk factor of mortality associated with over twofold increase of death hazard.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations